Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$770M |
| 2 |
Crown Castle
CCI
|
+$678M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$557M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$437M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$1.22B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.04B |
| 3 |
Amazon
AMZN
|
+$661M |
| 4 |
SHPG
Shire pic
SHPG
|
+$478M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$457M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.25% |
| 2 | Consumer Discretionary | 17.77% |
| 3 | Healthcare | 14.23% |
| 4 | Communication Services | 13.04% |
| 5 | Financials | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Paycom
PAYC
$10.8B
| $121M | 0.13% |
1,764,706
-398,076
| -18% | -$25.6M |
|
127
CDW
CDW
$18.5B
| $121M | 0.13% |
1,927,249
-145,161
| -7% | -$8.68M |
|
128
Caterpillar
CAT
$368B
| $117M | 0.12% |
+1,090,849
| New | +$111M |
|
129
MACOM Technology Solutions
MTSI
$20.3B
| $116M | 0.12% |
2,075,169
-152,213
| -7% | -$8.21M |
|
130
Edwards Lifesciences
EW
$52B
| $115M | 0.12% |
2,919,174
+14,496
| +0.5% | +$529K |
|
|
SRCL
131
DELISTED
Stericycle Inc
SRCL
| $114M | 0.12% |
1,489,121
+71,623
| +5% | +$5.88M |
|
|
SUM
132
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $113M | 0.12% |
4,030,475
-142,406
| -3% | -$3.71M |
|
|
CLVS
133
DELISTED
Clovis Oncology, Inc.
CLVS
| $111M | 0.12% |
1,185,177
+817,677
| +222% | +$50M |
|
134
Aptiv
APTV
$9.5B
| $111M | 0.12% |
1,262,882
-31,733
| -2% | -$2.65M |
|
135
DXC Technology
DXC
$1.79B
| $110M | 0.12% |
+1,659,309
| New | +$110M |
|
136
Chevron
CVX
$396B
| $110M | 0.12% |
1,052,765
-114,523
| -10% | -$12.1M |
|
137
Procter & Gamble
PG
$334B
| $110M | 0.12% |
1,257,402
-121
| -0% | -$10.7K |
|
|
CONE
138
DELISTED
CyrusOne Inc Common Stock
CONE
| $109M | 0.12% |
1,962,958
-509,574
| -21% | -$28.2M |
|
139
Zimmer Biomet
ZBH
$19.2B
| $108M | 0.11% |
866,822
+51,168
| +6% | +$6.07M |
|
140
Pinnacle Financial Partners Inc
PNFP
$15.3B
| $107M | 0.11% |
1,709,510
+82,643
| +5% | +$5.24M |
|
141
Xcel Energy
XEL
$47.8B
| $107M | 0.11% |
2,326,149
| – | – |
|
142
Patterson-UTI
PTEN
$4.74B
| $107M | 0.11% |
5,282,262
-519,360
| -9% | -$11.3M |
|
143
eBay
EBAY
$47B
| $106M | 0.11% |
3,045,886
-20,014
| -0.7% | -$685K |
|
|
WPX
144
DELISTED
WPX Energy, Inc.
WPX
| $106M | 0.11% |
10,995,002
+2,611,802
| +31% | +$29.8M |
|
|
TFCFA
145
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $106M | 0.11% |
3,746,877
+615,992
| +20% | +$17.7M |
|
146
Aramark
ARMK
$15.3B
| $105M | 0.11% |
3,558,910
-63,757
| -2% | -$1.75M |
|
147
CMS Energy
CMS
$21.4B
| $105M | 0.11% |
2,270,946
| – | – |
|
|
GXP
148
DELISTED
Great Plains Energy Incorporated
GXP
| $104M | 0.11% |
+3,566,958
| New | +$104M |
|
149
Fortis
FTS
$27.9B
| $103M | 0.11% |
2,940,746
+68,029
| +2% | +$2.26M |
|
150
PTC
PTC
$17.1B
| $103M | 0.11% |
1,874,574
-141,729
| -7% | -$7.81M |
|
Similar funds
Jennison Associates's Q2 2017 Portfolio in Review
As of Q2 2017, Jennison Associates held 698 positions worth $94.3B, up 1.1% from $93.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jennison Associates withdrew a net $3.11B in Q2 2017, closing 61 positions and reducing 332 holdings. Its most notable exit was NXP Semiconductors, an estimated $452M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Newell Brands worth $125M.
- Jennison Associates's largest Q2 2017 buy was Newell Brands: 2,328,211 shares worth $125M.
- Jennison Associates added most to McDonald's in Q2 2017, an estimated $770M increase.
- Jennison Associates's biggest Q2 2017 reduction was Nike, cutting an estimated $1.22B.
- Jennison Associates fully exited NXP Semiconductors in Q2 2017, selling an estimated $452M.
- Jennison Associates's ten largest holdings make up 27% of its $94.3B portfolio in Q2 2017.
- Jennison Associates opened 62 new positions and closed 61 in Q2 2017.
- Jennison Associates's portfolio value rose 1.1% quarter-over-quarter to $94.3B.
Based on Jennison Associates's 13F filing for Q2 2017, filed 4 Aug 2017.